Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154061 · ClinicalTrials.gov registry record · NA
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02154061 is a NA study that has completed, run by Emory University. The registered enrollment target is 33 participants.
The verdict
NCT02154061, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of the study is to better understand how the use of antibiotics changes micro-organisms in the intestines. The change to micro-organisms in the intestines may change the body's vaccine immune response and alter the effectiveness of the IIV (seasonal flu) vaccine. In particular, the investigators will be looking at certain markers in blood after vaccination with IIV (seasonal flu vaccine) with or without the use of antibiotics before vaccination. There will be two randomized groups. Group A will start taking antibiotic by mouth 3 days prior to vaccination and continue taking antibiotics the day of vaccination and one day after vaccination for a total of 5 days. Group B will only receive the IIV (seasonal flu vaccine) and will not take any antibiotics. The investigators hope to enroll 50 subjects at Emory.
Interventions
- DRUG Vancomycin
- DRUG Metronidazole
- DRUG Neomycin
- DRUG IIV Flu Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02154061
The ClinicalTrials.gov registry entry for NCT02154061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vancomycin is the first listed.
NCT02154061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02154061 about?
NCT02154061 is a clinical study titled "Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics". The purpose of the study is to better understand how the use of antibiotics changes micro-organisms in the intestines. The change to micro-organisms in the intestines may change the body's vaccine immune response and alter the effectiveness of the IIV (seasonal flu) vaccine. In particular, the inve...
What is the current status of trial NCT02154061?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2015-04. Estimated completion is 2017-05-26.
What interventions are being tested in trial NCT02154061?
The interventions under investigation include: Vancomycin (DRUG), Metronidazole (DRUG), Neomycin (DRUG), IIV Flu Vaccine (DRUG).
Who is sponsoring clinical trial NCT02154061?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.